DE68924605D1 - Verfahren zur induzierbaren genexpression unter verwendung eines dhfr-gens. - Google Patents
Verfahren zur induzierbaren genexpression unter verwendung eines dhfr-gens.Info
- Publication number
- DE68924605D1 DE68924605D1 DE68924605T DE68924605T DE68924605D1 DE 68924605 D1 DE68924605 D1 DE 68924605D1 DE 68924605 T DE68924605 T DE 68924605T DE 68924605 T DE68924605 T DE 68924605T DE 68924605 D1 DE68924605 D1 DE 68924605D1
- Authority
- DE
- Germany
- Prior art keywords
- interest
- protein
- dhfr
- cultured
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28183388A | 1988-12-08 | 1988-12-08 | |
PCT/US1989/005412 WO1990006363A1 (en) | 1988-12-08 | 1989-11-30 | Expression induction method employing mutant dhfr gene |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68924605D1 true DE68924605D1 (de) | 1995-11-23 |
DE68924605T2 DE68924605T2 (de) | 1996-05-15 |
Family
ID=23078969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68924605T Expired - Fee Related DE68924605T2 (de) | 1988-12-08 | 1989-11-30 | Verfahren zur induzierbaren genexpression unter verwendung eines dhfr-gens. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5741682A (de) |
EP (1) | EP0555203B1 (de) |
JP (1) | JP3456992B2 (de) |
AT (1) | ATE129289T1 (de) |
AU (2) | AU4741090A (de) |
CA (1) | CA2004632C (de) |
DE (1) | DE68924605T2 (de) |
WO (1) | WO1990006363A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69032809T2 (de) * | 1989-11-06 | 1999-07-08 | Cell Genesys Inc | Herstellung von Proteinen mittels homologer Rekombination |
US5714345A (en) * | 1990-12-24 | 1998-02-03 | Pharmaceutical Proteins Limited | Increased expression of a gene by a second transferred mammary gland specific sequence transgenic |
GB9028062D0 (en) * | 1990-12-24 | 1991-02-13 | Agricultural & Food Res | Production of transgenic animals |
US6156514A (en) | 1998-12-03 | 2000-12-05 | Sunol Molecular Corporation | Methods for making recombinant cells |
DE60024659T2 (de) * | 1999-10-13 | 2006-08-17 | Immunex Corp., Thousand Oaks | Vektoren und verfahren für rekombinante proteinexpression |
FR2818539B1 (fr) † | 2000-12-22 | 2004-04-30 | Oreal | Composition pour la teinture d'oxydation des fibres keratiniques comprenant au moins 4,5 ou 3,4 diamino pyrazole ou triamino pyrazole et au moins un compose cellulosique particulier, et procede de teinture |
CN1304411C (zh) * | 2002-02-21 | 2007-03-14 | 本元正阳基因技术股份有限公司 | 一种突变型二氢叶酸还原酶基因及其在哺乳动物细胞基因表达中的应用 |
AU2008339985C1 (en) | 2007-12-21 | 2012-12-20 | Novartis Ag | Mammalian expression vector |
BRPI0821401A2 (pt) * | 2007-12-21 | 2014-10-14 | Novartis Ag | Compostos orgânicos |
KR101030978B1 (ko) * | 2008-07-10 | 2011-04-28 | (주) 에이프로젠 | 동물세포용 재조합 발현벡터 |
JP7214962B2 (ja) * | 2018-01-17 | 2023-01-31 | 東ソー株式会社 | アルカリホスファターゼ高発現動物細胞 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4442203A (en) * | 1981-06-30 | 1984-04-10 | Massachusetts Institute Of Technology | Gene amplification assay for detecting tumor promoters |
US4656134A (en) * | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US4766075A (en) * | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
AU572108B2 (en) * | 1983-01-19 | 1988-05-05 | Genentech Inc. | Human tpa production using vectors coding for dhfr protein |
US4965196A (en) * | 1983-01-19 | 1990-10-23 | Genentech, Inc. | Polycistronic expression vector construction |
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US4663281A (en) * | 1984-03-22 | 1987-05-05 | Mass Institute Of Technology | Enhanced production of proteinaceous materials in eucaryotic cells |
EP0221955A4 (de) * | 1985-05-01 | 1988-12-22 | Genetics Inst | Hochstufige verstärkung und expression von exogener dns. |
GB8601597D0 (en) * | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
AU582288B2 (en) * | 1986-03-07 | 1989-03-16 | Damon Biotech Inc. | Vector and method for achieving high level expression in eukaryotic cells |
JP2585532B2 (ja) * | 1986-05-10 | 1997-02-26 | 三井東圧化学株式会社 | 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてt−PAを生産する方法 |
-
1989
- 1989-11-30 DE DE68924605T patent/DE68924605T2/de not_active Expired - Fee Related
- 1989-11-30 EP EP90901297A patent/EP0555203B1/de not_active Expired - Lifetime
- 1989-11-30 JP JP50134990A patent/JP3456992B2/ja not_active Expired - Lifetime
- 1989-11-30 AT AT90901297T patent/ATE129289T1/de active
- 1989-11-30 AU AU47410/90A patent/AU4741090A/en active Granted
- 1989-11-30 WO PCT/US1989/005412 patent/WO1990006363A1/en active IP Right Grant
- 1989-11-30 AU AU47410/90A patent/AU644352B2/en not_active Ceased
- 1989-12-05 CA CA002004632A patent/CA2004632C/en not_active Expired - Lifetime
-
1995
- 1995-01-20 US US08/376,073 patent/US5741682A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE68924605T2 (de) | 1996-05-15 |
ATE129289T1 (de) | 1995-11-15 |
CA2004632C (en) | 1999-01-19 |
CA2004632A1 (en) | 1990-06-08 |
EP0555203B1 (de) | 1995-10-18 |
JP3456992B2 (ja) | 2003-10-14 |
EP0555203A4 (de) | 1992-03-31 |
AU4741090A (en) | 1990-06-26 |
US5741682A (en) | 1998-04-21 |
WO1990006363A1 (en) | 1990-06-14 |
JPH04502254A (ja) | 1992-04-23 |
AU644352B2 (en) | 1993-12-09 |
EP0555203A1 (de) | 1993-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Newbold et al. | Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene | |
Wu et al. | Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. | |
Rao et al. | A tripotential glial precursor cell is present in the developing spinal cord | |
DE68924605D1 (de) | Verfahren zur induzierbaren genexpression unter verwendung eines dhfr-gens. | |
MX9606476A (es) | Inhibicion citoplasmica de expresion de genes. | |
Choi et al. | The role of DNA polymerase η in UV mutational spectra | |
Preskey et al. | Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts | |
DK0633929T3 (da) | Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener | |
US20090209036A1 (en) | Method for Accelerating Somatic Mutations and use Thereof in Proteomics | |
Yoshikawa et al. | Flow cytometry: an improved method for the selection of highly productive gene‐amplified CHO cells using flow cytometry | |
Ogawa et al. | Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes | |
DE69938722D1 (de) | Verfahren zur herstellung von heterologen polypeptiden in trichothecene mangelmutanten filamentlösen pilzen | |
Zhu et al. | Derivation and characterization of sheep bone marrow-derived mesenchymal stem cells induced with telomerase reverse transcriptase | |
SCHER et al. | Direct isolation and characterization of “flat” SV40-transformed cells | |
Eves et al. | Conditional immortalization of neuronal cells from postmitotic cultures and adult CNS | |
Bhargava et al. | Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells | |
Niculescu | Developmental and non developmental polyploidy in xenic and axenic cultured stem cell lines of Entamoeba invadens and E. histolytica | |
EPHRUSSI et al. | Regulation of the cell cycle in mammalian cells: inferences and speculations based on observations of interspecific somatic hybrids | |
Köhler | Derivation and diversification of monoclonal antibodies | |
US5514552A (en) | Hybrid neuronal cell lines compositions and methods | |
Lelievre et al. | Contact inhibition-plasma membranes enzymatic activities in cultured cell lines | |
Long et al. | Enhancing the establishment efficiency of hybridoma cells: use of irradiated human diploid fibroblast feeder layers | |
Wyllie et al. | A phenotypically and karyotypically stable human thyroid epithelial line conditionally immortalized by SV40 large T antigen | |
Rovera et al. | Isolation and characterization of a subline of Friend erythroleukemia cells that differentiate in tissue culture in the absence of inducers | |
CN104995299A (zh) | 表达盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |